{
    "nctId": "NCT02514486",
    "briefTitle": "Assessment of Cancer Concerns at the End of Treatment (ACE)",
    "officialTitle": "Assessment of Cancer Concerns at the End of Treatment (ACE)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer(BC) Survivors",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 332,
    "primaryOutcomeMeasure": "Completion of Questionnaire",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Diagnosed with invasive, non-metastatic BC (Stage I, II, or III) without hematogenous or distant metastases\n2. Have completed initial treatment (chemotherapy, radiotherapy, and/or surgery). May still be receiving hormonal or targeted therapy (e.g., tamoxifen, aromatase inhibitors).\n3. Within 1 year of completing primary treatment\n4. Scheduled for an EOT visit\n5. Age 18 years or older\n6. Can understand written English\n7. Have internet access and a working email address\n\nExclusion Criteria:\n\n1. Diagnosed with non-invasive (Stage 0/DCIS) or metastatic (Stage IV) cancer or hematogenous or distant metastatic disease\n2. No working email address -",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}